View Exam | PowerPak

1. Which of the following is the primary mechanism of action of combination hormonal contraceptives (CHCs):

A. Creating an unfavorable cervical mucous B. Manipulating the endometrial lining to make implantation difficult C. Inhibiting ovulation D. Causing fallopian tube spasm

2. Which one of the following are more common with use of the vaginal ring as compared with oral contraceptives:

A. Nausea B. Acne C. Vaginitis D. Irritability

3. Which one of the following has the highest risk for a venous thromboembolism:

A. A woman using a CHC for 1 year B. A woman who had a baby 3 weeks ago C. A woman that is 32 weeks pregnant D. A woman who had a levonorgestrel IUD inserted 1 year ago

4. Which of the following best describes the pharmacokinetic (PK) profile of the contraceptive transdermal patch compared with a combined oral contraceptive (COC):

A. Lower steady state concentration of estradiol in the patch B. Lower peak concentration of estradiol in the patch C. Lower area under the curve (AUC) levels in the patch D. Lower estrogen receptor binding affinity in the patch

5. Which one of the following medications is least likely to interact with a non-oral combined hormonal contraceptive:

A. Phenytoin B. Amoxicillin C. Lamotrigine D. Levothyroxine

6. Of the following, which patient would be the best candidate for the contraceptive implant:

A. Woman, 32 years of age with active breast cancer B. Patient with advanced cirrhosis C. 24 year old with BMI of 32 D. Migraineur, 18 years of age, with aura

7. All of the following have been used to treat bleeding irregularities with progestin non-oral contraceptives, EXCEPT:

A. Naproxen B. Oral estradiol C. Ibuprofen D. Vitamin E

8. Which of the following statements regarding intrauterine device (IUD) use is TRUE:

A. When inserting an IUD, prophylactic antibiotics are usually recommended B. A woman with a distorted endometrial cavity can safely use an IUD C. Adolescent women are ideal candidates for IUDs D. IUDs are not a cost-effective form of birth control

9. In addition to contraception, the levonorgestrel IUD can be useful to treat which of the following conditions:

A. Obesity B. Urinary tract infections C. Chlamydia D. Menorrhagia

10. Which non-oral hormonal contraceptive can a patient use without placement by a health care provider?

A. Vaginal ring B. Etonogestrel insert C. Levonorgestrel-IUD D. None of the above

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is the primary mechanism of action of combination hormonal contraceptives (CHCs):

2. Which one of the following are more common with use of the vaginal ring as compared with oral contraceptives:

3. Which one of the following has the highest risk for a venous thromboembolism:

4. Which of the following best describes the pharmacokinetic (PK) profile of the contraceptive transdermal patch compared with a combined oral contraceptive (COC):

5. Which one of the following medications is least likely to interact with a non-oral combined hormonal contraceptive:

6. Of the following, which patient would be the best candidate for the contraceptive implant:

7. All of the following have been used to treat bleeding irregularities with progestin non-oral contraceptives, EXCEPT:

8. Which of the following statements regarding intrauterine device (IUD) use is TRUE:

9. In addition to contraception, the levonorgestrel IUD can be useful to treat which of the following conditions:

10. Which non-oral hormonal contraceptive can a patient use without placement by a health care provider?

« Return to Activity

Maintenance is scheduled for 05/16/2024 5:00 PM EST - 05/17/2024 5:00 AM EST.

The shopping cart is empty

Customers who Purchasedthis Activity also Purchased

{{recommendationsA.Title}}

{{recommendationsB.Title}}

1. Which of the following is the primary mechanism of action of combination hormonal contraceptives (CHCs):

2. Which one of the following are more common with use of the vaginal ring as compared with oral contraceptives:

3. Which one of the following has the highest risk for a venous thromboembolism:

4. Which of the following best describes the pharmacokinetic (PK) profile of the contraceptive transdermal patch compared with a combined oral contraceptive (COC):

5. Which one of the following medications is least likely to interact with a non-oral combined hormonal contraceptive:

6. Of the following, which patient would be the best candidate for the contraceptive implant:

7. All of the following have been used to treat bleeding irregularities with progestin non-oral contraceptives, EXCEPT:

8. Which of the following statements regarding intrauterine device (IUD) use is TRUE:

9. In addition to contraception, the levonorgestrel IUD can be useful to treat which of the following conditions:

10. Which non-oral hormonal contraceptive can a patient use without placement by a health care provider?

« Return to Activity

Customers who Purchased
this Activity also Purchased